Document is current
Any future updates will be listed below
-
Authors
Bal, Susan https://orcid.org/0000-0002-8206-8919
Estrada-Merly, Noel
Costa, Luciano J. https://orcid.org/0000-0001-5362-2469
Qazilbash, Muzaffar H. https://orcid.org/0000-0003-2876-2886
Kumar, Shaji https://orcid.org/0000-0001-5392-9284
D’Souza, Anita
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01 HL166339)
- License Information
-
More Information
Article History
Received: 11 September 2023
Revised: 24 October 2023
Accepted: 3 November 2023
First Online: 15 November 2023
Conflict of interest
: SB received an honorarium from AbbVie, Adaptive Biotechnologies, Bristol Myers Squibb, Janssen, and MJH Lifesciences. NE, SK, and MQ report no conflicts of interest relevant to this work. LJC reports institution research funding from AbbVie, BMS, Janssen, Amgen, Genentech, consulting/advisory activity with BMS, Janssen, Pfizer, Amgen, Sanofi, AbbVie, Adaptive biotechnology. AD reports institutional research funding from Abbvie, Caelum, Janssen, Novartis, Prothena, Sanofi, Sorrento, TeneoBio, consulting/advisory board activity with BMS, Janssen, Pfizer, Prothena.
